Faculty will review and discuss complicated aspects of diagnosing and treating patients with epilepsy with a focus on tertiary aspects in this Clinical Epilepsy III course. The recognition of acute repetitive seizures and status epilepticus in their various forms from subtle to convulsive will be discussed in detail. Management options will be reviewed in various settings, including in the home, the emergency room, inpatient, and the intensive care unit. The latest definition for drug resistant epilepsy will be discussed and how to apply it to an individual patient. Therapeutic options beyond antiepileptic drugs will be reviewed in detail, including diet, devices, surgery, and marijuana. Faculty will review the latest advances in each topic discussed. Issues most useful to clinical practice will be emphasized by using a case-based approach. Video case presentations will be used to illustrate different seizure types in an engaging manner with the audience.
This program complements C172: Clinical Epilepsy I: Basics and C182: Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly, but covers independent topics.
Participants should be able to recognize when a patient meets criteria for acute repetitive seizures, status epilepticus, and drug resistant epilepsy. Participants should be able to know the latest therapeutic approaches to these patients in a variety of settings from home, to outpatient clinic, and in the hospital. Participants should recognize when to consider treatments in addition to AEDs and which ones to consider given a specific patient seizure type and clinical scenario. Participants will become more familiar with classifying seizures through video presentations.
Medical Knowledge, Patient Care
Program Speakers - Tentative
3:30 PM - 3:35 PM
3:35 PM - 4:10 PM
Acute Repetitive Seizures and Status Epilepticus
Tobias Loddenkemper MD
4:10 PM - 4:45 PM
Beyond AEDs - Surgery, Devices, Diet, or Marijuana?
Elson L. So MD, FAAN
4:45 PM - 5:20 PM
Video-EEG Cases: You Make the Call
William O. Tatum DO, FAAN
5:20 PM - 5:30 PM
Questions and Answers
Tobias Loddenkemper, MD
Dr. Loddenkemper has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Zogenix, Upsher Smith.
Elson L. So, MD, FAAN
Dr. So has nothing to disclose.
William O. Tatum, IV, DO, FAAN
Dr. Tatum has received personal compensation in an editorial capacity for Elsevier. Dr. Tatum has received royalty, license fees, or contractual rights payments from Demos Medical Publishing, LLC.
Ready to register for the 2018 AAN Annual Meeting?